These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3843 related items for PubMed ID: 7081141

  • 1. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD, Millar JL, McElwain TJ.
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [Abstract] [Full Text] [Related]

  • 2. [Enhancement of MeCCNU potency (chemosensitization) by misonidazole in a human melanoma xenograft system].
    Osieka R, Glatte P, Haedecke U, Schmidt CG.
    Strahlentherapie; 1982 Oct; 158(10):620-9. PubMed ID: 7179344
    [Abstract] [Full Text] [Related]

  • 3. Chemosensitization of mouse tumors by misonidazole.
    Randhawa VS, Stewart FA, Denekamp J.
    Int J Radiat Oncol Biol Phys; 1982 Oct; 8(3-4):671-4. PubMed ID: 7107397
    [Abstract] [Full Text] [Related]

  • 4. The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
    Twentyman PR.
    Cancer Clin Trials; 1980 Oct; 3(3):253-6. PubMed ID: 7438322
    [Abstract] [Full Text] [Related]

  • 5. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M, Altermatt HJ, Ris HB, Althaus U, Rüegg C, Liénard D, Lejeune FJ.
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.
    Clement JJ, Gorman MS, Wodinsky I, Catane R, Johnson RK.
    Cancer Res; 1980 Nov; 40(11):4165-72. PubMed ID: 7471058
    [Abstract] [Full Text] [Related]

  • 7. Effect of a new bifunctional nitrosoureido derivative on human colorectal tumor xenografts.
    Kopper L, Lapis K, Csányi E, Horváth T.
    Anticancer Res; 1981 Nov; 1(4):229-33. PubMed ID: 7345967
    [Abstract] [Full Text] [Related]

  • 8. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT, Siemann DW.
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [Abstract] [Full Text] [Related]

  • 9. Acute in vivo resistance in high-dose therapy.
    Teicher BA, Ara G, Keyes SR, Herbst RS, Frei E.
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of cytotoxic drugs by misonidazole (MISO) in Lewis lung tumors of different sizes, and mouse bone marrow.
    Spooner D, Peacock JH, Stephens TC.
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(3-4):643-6. PubMed ID: 7107390
    [Abstract] [Full Text] [Related]

  • 11. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
    Pierson HF, Meadows GG.
    Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435
    [Abstract] [Full Text] [Related]

  • 12. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L, Ito H, Hunter N.
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [Abstract] [Full Text] [Related]

  • 13. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
    Hampel N, Persky L.
    Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
    [Abstract] [Full Text] [Related]

  • 14. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
    Teicher BA, Crawford JM, Holden SA, Cathcart KN.
    Cancer Res; 1987 Oct 01; 47(19):5036-41. PubMed ID: 3113727
    [Abstract] [Full Text] [Related]

  • 15. Radiosensitizing effect of misonidazole in fractionated gamma-ray treatment of a human malignant melanoma grown in athymic nude mice.
    Rofstad EK, Brustad T.
    Br J Radiol; 1979 May 01; 52(617):393-7. PubMed ID: 444837
    [Abstract] [Full Text] [Related]

  • 16. Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft.
    Lilley ER, Rosenberg MC, Elion GB, Colvin OM, Bigner DD, Friedman HS.
    Cancer Res; 1990 Jan 15; 50(2):284-7. PubMed ID: 2295068
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clonogenic cell survival curves for human melanoma xenografts using agar diffusion chamber and lung colony assays.
    Selby PJ, Thomas JM.
    Br J Cancer Suppl; 1980 Apr 15; 4():150-3. PubMed ID: 6932919
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P, Workman P.
    Br J Cancer; 1982 Mar 15; 45(3):447-55. PubMed ID: 7073938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 193.